1. Pomalidomide plus low‐dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure. (6th October 2019) Authors: Siegel, David S.; Schiller, Gary J.; Song, Kevin W.; Agajanian, Richy; Stockerl‐Goldstein, Keith; Kaya, Hakan; Sebag, Michael; Samaras, Christy; Malek, Ehsan; Talamo, Giampaolo; Seet, Christopher S.; Mouro, Jorge; Pierceall, William E.; Zafar, Faiza; Chung, Weiyuan; Srinivasan, Shankar; Agarwal, ... Journal: British journal of haematology Issue: Volume 188:Number 4(2020) Page Start: 501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial. Issue 10027 (9th April 2016) Authors: Lonial, Sagar; Weiss, Brendan M; Usmani, Saad Z; Singhal, Seema; Chari, Ajai; Bahlis, Nizar J; Belch, Andrew; Krishnan, Amrita; Vescio, Robert A; Mateos, Maria Victoria; Mazumder, Amitabha; Orlowski, Robert Z; Sutherland, Heather J; Bladé, Joan; Scott, Emma C; Oriol, Albert; Berdeja, Jesus; Ghari... Journal: Lancet Issue: Volume 387:Issue 10027(2016) Page Start: 1551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Retrospective study of treatment patterns and outcomes post‐lenalidomide for multiple myeloma in Canada. (27th June 2021) Authors: Reece, Donna E.; Masih‐Khan, Esther; Atenafu, Ehetu G.; Jimenez‐Zepeda, Victor H.; McCurdy, Arleigh; Song, Kevin; LeBlanc, Richard; Sebag, Michael; White, Darrell; Cherniawsky, Hannah; Reiman, Anthony; Stakiw, Julie; Louzada, Martha L.; Kotb, Rami; Aslam, Muhammad; Gul, Engin; Venner, Christopher P. Journal: European journal of haematology Issue: Volume 107:Number 4(2021) Page Start: 416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Selinexor‐based regimens in patients with multiple myeloma after prior anti‐B‐cell maturation antigen treatment. Issue 4 (30th September 2022) Authors: Baljevic, Muhamed; Gasparetto, Cristina; Schiller, Gary J.; Tuchman, Sascha A.; Callander, Natalie S.; Lentzsch, Suzanne; Monge, Jorge; Kotb, Rami; Bahlis, Nizar J.; White, Darrell; Chen, Christine I.; Sutherland, Heather J.; Madan, Sumit; LeBlanc, Richard; Sebag, Michael; Venner, Christopher P.;... Journal: EJHaem Issue: Volume 3:Issue 4(2022) Page Start: 1270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi‐institutional report from the Canadian Myeloma Research Group (CMRG) Database. Issue 4 (31st August 2022) Authors: McCurdy, Arleigh; Louzada, Martha; Venner, Christopher P.; Visram, Alissa; Masih‐Khan, Esther; Kardjadj, Moustafa; Jimenez‐Zepeda, Victor H.; LeBlanc, Richard; Sebag, Michael; Song, Kevin; White, Darrell; Mian, Hira; Stakiw, Julie; Reiman, Anthony; Aslam, Muhammad; Kotb, Rami; Gul, Engin; Reece, ... Journal: EJHaem Issue: Volume 3:Issue 4(2022) Page Start: 1252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma. Issue 1 (8th November 2020) Authors: Gasparetto, Cristina; Lentzsch, Suzanne; Schiller, Gary; Callander, Natalie; Tuchman, Sascha; Chen, Christine; White, Darrell; Kotb, Rami; Sutherland, Heather; Sebag, Michael; Baljevic, Muhamed; Bensinger, William; LeBlanc, Richard; Venner, Chris; Bahlis, Nizar; Rossi, Adriana; Biran, Noa; Sheeha... Journal: EJHaem Issue: Volume 2:Issue 1(2021) Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database. (5th April 2022) Authors: LeBlanc, Richard; Mian, Hira; Reece, Donna; Masih‐Khan, Esther; Kardjadj, Moustafa; Jimenez‐Zepeda, Victor H.; McCurdy, Arleigh; Song, Kevin; Sebag, Michael; Louzada, Martha; White, Darrell; Stakiw, Julie; Kotb, Rami; Reiman, Anthony; Aslam, Muhammad; Gul, Engin; Venner, Christopher P. Journal: British journal of haematology Issue: Volume 198:Number 1(2022) Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Practical Approaches to the Use of Lenalidomide in Multiple Myeloma: A Canadian Consensus. (14th October 2012) Authors: Reece, Donna; Kouroukis, C. Tom; LeBlanc, Richard; Sebag, Michael; Song, Kevin; Ashkenas, John Other Names: Palumbo Antonio Academic Editor. Journal: Advances in hematology Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial. Issue 6 (June 2022) Authors: Dimopoulos, Meletios A; Richardson, Paul G; Bahlis, Nizar J; Grosicki, Sebastian; Cavo, Michele; Beksaç, Meral; Legieć, Wojciech; Liberati, Anna M; Goldschmidt, Hartmut; Belch, Andrew; Magen, Hila; Larocca, Alessandra; Laubach, Jacob P; Petrucci, Maria T; Reece, Donna; White, Darrell; Mateos, Mar... Journal: Lancet Issue: Volume 9:Issue 6(2022) Page Start: e403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pomalidomide, dexamethasone, and daratumumab immediately after lenalidomide-based treatment in patients with multiple myeloma: updated efficacy, safety, and health-related quality of life results from the phase 2 MM-014 trial. Issue 6 (12th May 2022) Authors: Bahlis, Nizar J.; Siegel, David S.; Schiller, Gary J.; Samaras, Christy; Sebag, Michael; Berdeja, Jesus; Ganguly, Siddhartha; Matous, Jeffrey; Song, Kevin; Seet, Christopher S.; Acosta-Rivera, Mirelis; Bar, Michael; Quick, Donald; Anz, Bertrand; Fonseca, Gustavo; Chung, Weiyuan; Lee, Kim; Mouro, ... Journal: Leukemia & lymphoma Issue: Volume 63:Issue 6(2022) Page Start: 1407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗